Association of SRD5A2 variants and serum androstane-3α,17β-diol glucuronide concentration in Chinese elderly men

Clinical Chemistry

Volumn 56, Issue 11, 2010, Pages 1742-1749

  Jiang, Jieying ^a   Tang, Nelson L S ^a,b   Ohlsson, Claes ^c   Eriksson, Anna L ^c   Vandenput, Liesbeth ^c   Liao, ChenDi ^a   Wang, Xingyan ^a   Chan, Frank W K ^a   Kwok, Anthony ^a   Orwoll, Eric ^d   Kwok, Timothy C Y ^a   Woo, Jean ^a   Leung, Ping Chung ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b Li Ka Shing Institute of Health Sciences   (Hong Kong)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANE 3ALPHA, 17BETA DIOL GLUCURONIDE; ANDROSTANE 3ALPHA, L7BETA DIOL 3 GLUCURONIDE; ANDROSTANE DERIVATIVE; ANDROSTANOLONE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; STEROID 5ALPHA REDUCTASE 2; UNCLASSIFIED DRUG; ANDROSTANE 3,17 DIOL GLUCURONIDE; ANDROSTANE-3,17-DIOL GLUCURONIDE; ANDROSTANEDIOL; DRUG DERIVATIVE; MEMBRANE PROTEIN; SRD5A2 PROTEIN, HUMAN; STEROID 5ALPHA REDUCTASE; TESTOSTERONE;

AGED; ALLELE; ARTICLE; BLOOD LEVEL; CHINESE; CIRCULATION; COHORT ANALYSIS; CONJUGATE; CORRELATION ANALYSIS; GAS CHROMATOGRAPHY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HORMONE BLOOD LEVEL; HUMAN; MALE; MASS SPECTROMETRY; MELTING POINT; METABOLITE; MISSENSE MUTATION; MULTIPLE SCLEROSIS; NORMAL HUMAN; POLYMERASE CHAIN REACTION; SERUM; SEX; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; TEMPERATURE; ASIAN; BLOOD; GENETICS; HONG KONG; LIQUID CHROMATOGRAPHY;

AGED; ANDROSTANE-3,17-DIOL; ASIAN CONTINENTAL ANCESTRY GROUP; CHROMATOGRAPHY, GAS; CHROMATOGRAPHY, LIQUID; DIHYDROTESTOSTERONE; HAPLOTYPES; HONG KONG; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MASS SPECTROMETRY; MEMBRANE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 78149478171     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2010.150607     Document Type: Article

References (29)

1. Yeap BB. Testosterone and ill-health in aging men. Nat Clin Pract Endocrinol Metab 2009;5:113-21.
2. Hsing AW, Reichardt JK, Stanczyk FZ. Hormones and prostate cancer: current perspectives and future directions. Prostate 2002;52:213-35.
3. Severi G, Morris HA, MacInnis RJ, English DR, Tilley W, Hopper JL, et al. Circulating steroid hormones and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006;15:86-91.
4. Ahn J, Schumacher FR, Berndt SI, Pfeiffer R, Albanes D, Andriole GL, et al. Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3). Hum Mol Genet 2009;18:3749-57.
5. Allen NE, Forrest MS, Key TJ. The association between polymorphisms in the CYP17 and 5alpha-reductase (SRD5A2) genes and serum androgen concentrations in men. Cancer Epidemiol Biomarkers Prev 2001;10:185-9.
6. Hayes VM, Severi G, Padilla EJ, Morris HA, Tilley WD, Southey MC, et al. 5alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia. Int J Cancer 2007;120:776-80.
7. Jiang J, Tang NL, Ohlsson C, Eriksson AL, Vandenput L, Chan FW, et al. Association of genetic variations in aromatase gene with serum estrogen and estrogen/testosterone ratio in Chinese elderly men. Clinica Chim Acta 2009;411:53-8.
8. Yu MW, Cheng SW, Lin MW, Yang SY, Liaw YF, Chang HC, et al. Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst 2000;92:2023-8.
9. Eriksson AL, Lorentzon M, Vandenput L, Labrie F, Lindersson M, Syvanen AC, et al. Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in men. J Clin Endocrinol Metab 2009;94:1033-41.
10. Olson SH, Bandera EV, Orlow I. Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review. Am J Epidemiol 2007;165:235-45.
11. Kuijper EA, Lambalk CB, Boomsma DI, van der Sluis S, Blankenstein MA, de Geus EJ, Posthuma D. Heritability of reproductive hormones in adult male twins. Hum Reprod 2007;22:2153-9.
12. Ring HZ, Lessov CN, Reed T, Marcus R, Holloway L, Swan GE, Carmelli D. Heritability of plasma sex hormones and hormone binding globulin in adult male twins. J Clin Endocrinol Metab 2005;90:3653-8.
13. Hardy J, Singleton A. Genomewide association studies and human disease. N Engl J Med 2009;360:1759-68.
14. Perry JR, Stolk L, Franceschini N, Lunetta KL, Zhai G, McArdle PF, et al. Meta-analysis of genome-wide association data identifies two loci influencing age at menarche. Nat Genet 2009;41:648-50.
15. Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L, et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009;41:666-76.
16. Willer CJ, Speliotes EK, Loos RJ, Li S, Lindgren CM, Heid IM, et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 2009;41:25-34.
17. Carrie J. Bagatell CJ, Bremner WJ, eds. Contemporary endocrinology: androgens in health and disease. New York: Humana Press; 2003.
18. Vandenput L, Labrie F, Mellstrom D, Swanson C, Knutsson T, Peeker R, et al. Serum levels of specific glucuronidated androgen metabolites predict BMD and prostate volume in elderly men. J Bone Miner Res 2007;22:220-7.
19. Vandenput L, Mellstrom D, Lorentzon M, Swanson C, Karlsson MK, Brandberg J, et al. Androgens and glucuronidated androgen metabolites are associated with metabolic risk factors in men. J Clin Endocrinol Metab 2007;92:4130-7.
20. Makridakis N, Ross RK, Pike MC, Chang L, Stanczyk FZ, Kolonel LN, et al. A prevalent missense substitution that modulates activity of prostatic steroid 5alpha-reductase. Cancer Res 1997;57:1020-2.
21. Hsing AW, Chen C, Chokkalingam AP, Gao YT, Dightman DA, Nguyen HT, et al. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2001;10:1077-82.
22. Horne BD, Camp NJ. Principal component analysis for selection of optimal SNP-sets that capture intragenic genetic variation. Genet Epidemiol 2004;26:11-21.
23. Lin Z, Altman RB. Finding haplotype tagging SNPs by use of principal components analysis. Am J Hum Genet 2004;75:850-61.
24. Meng Z, Zaykin DV, Xu CF, Wagner M, Ehm MG. Selection of genetic markers for association analyses, using linkage disequilibrium and haplotypes. Am J Hum Genet 2003;73:115-30.
25. Germer S, Higuchi R. Single-tube genotyping without oligonucleotide probes. Genome Res 1999;9:72-8.
26. Wang J, Chuang K, Ahluwalia M, Patel S, Umblas N, Mirel D, et al. High-throughput SNP genotyping by single-tube PCR with Tm-shift primers. Biotechniques 2005;39:885-93.
27. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-89.
28. Allen NE, Reichardt JK, Nguyen H, Key TJ. Association between two polymorphisms in the SRD5A2 gene and serum androgen concentrations in British men. Cancer Epidemiol Biomarkers Prev 2003;12:578-81.
29. Li Z, Habuchi T, Mitsumori K, Kamoto T, Kinoshitu H, Segawa T, et al. Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population. J Urol 2003;169:2378-81. (Pubitemid 36576804)